InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

- Current share price for RHT : $0.058

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$28 Change of Director's Interest Notice 28 Jun 2021 6:50PM $0.160 $0.058 fallen by 63.75%
$28 Appointment of Managing Director 28 Jun 2021 8:25AM $0.155 $0.058 fallen by 62.58%
$28 Secondary Trading Notice 11 Jun 2021 6:24PM $0.173 $0.058 fallen by 66.38%
$28 Application for quotation of securities - RHT 11 Jun 2021 6:13PM $0.173 $0.058 fallen by 66.38%
$28 Resignation of CEO & Management Changes 4 Jun 2021 9:01AM $0.195 $0.058 fallen by 70.26%
$28 Filing of Patent Application 24 May 2021 8:19AM $0.190 $0.058 fallen by 69.47%
$28 R&D Update - Molecular Medicine ASO Project 17 May 2021 8:16AM $0.185 $0.058 fallen by 68.65%
$28 Appendix 4C - quarterly 29 Apr 2021 8:14AM $0.200 $0.058 fallen by 71%
$28 Appointment of CFO & Company Secretary 8 Apr 2021 8:26AM $0.195 $0.058 fallen by 70.26%
$28 Change of Director's Interest Notice 9 Mar 2021 3:43PM $0.175 $0.058 fallen by 66.86%
$28 Secondary Trading Notice & Appendix 2A 9 Mar 2021 3:37PM $0.175 $0.058 fallen by 66.86%
$28 Half Yearly Report and Accounts 26 Feb 2021 12:36PM $0.195 $0.058 fallen by 70.26%
$28 HepaFat-AI receives CE Marking 24 Feb 2021 9:44AM $0.215 $0.058 fallen by 73.02%
$28 HepaFat-AI Receives TGA Approval 18 Feb 2021 11:19AM $0.195 $0.058 fallen by 70.26%
$28 Trading Halt 17 Feb 2021 2:21PM $0.195 $0.058 fallen by 70.26%
$28 Pause in Trading 17 Feb 2021 2:13PM $0.195 $0.058 fallen by 70.26%
$28 Appendix 4C - quarterly 28 Jan 2021 10:04AM $0.195 $0.058 fallen by 70.26%
$28 Secondary Trading Notice & Appendix 2A 12 Jan 2021 2:40PM $0.210 $0.058 fallen by 72.38%
$28 Secondary Trading Notice & Appendix 2A 31 Dec 2020 12:20PM $0.230 $0.058 fallen by 74.78%
$28 Secondary Trading Notice & Appendix 2A 29 Dec 2020 2:21PM $0.255 $0.058 fallen by 77.25%
$28 HepaFat-AI Incorporated into Blackford Analysis 24 Dec 2020 10:01AM $0.215 $0.058 fallen by 73.02%
$28 Secondary Trading Notice & Appendix 2A 11 Dec 2020 3:18PM $0.235 $0.058 fallen by 75.32%
$28 HepaFat-AI gains US FDA clearance 9 Dec 2020 10:23AM $0.155 $0.058 fallen by 62.58%
$28 Trading Halt 8 Dec 2020 10:49AM $0.155 $0.058 fallen by 62.58%
$28 Pause in Trading 8 Dec 2020 10:36AM $0.155 $0.058 fallen by 62.58%

176 - 200 of 531 results

Page 8 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.